Indraprastha Medical Corporation Ltd
INDRAMEDCOIndraprastha Medical Corporation Ltd
INDRAMEDCOPrice Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
28.93 | 8.37 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.91 | 6.64 | 0.47% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Indraprastha Medical Corporation Limited is engaged in healthcare business.
Peers
Compare with peersApollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Dr. Lal PathLabs Ltd
Global Health Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 757.57 | 766.18 | 753.45 | 788.64 | 831.46 | 614.06 | 891.28 | 1,108.70 | 1,261.59 | 1,304.50 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,072.83 | ||||||||||
Power & Fuel Cost | 25.16 | 20.91 | 19.26 | 19.70 | 21.16 | 17.18 | 20.56 | 25.22 | 26.01 | |||||||||||
Employee Cost | 181.56 | 190.26 | 194.01 | 200.21 | 213.93 | 197.71 | 213.92 | 246.70 | 261.61 | |||||||||||
Selling & Administrative Expenses | 74.10 | 76.58 | 72.29 | 78.20 | 83.66 | 186.62 | 292.12 | 405.34 | 462.43 | |||||||||||
Operating & Other expenses | 395.25 | 399.17 | 394.31 | 409.28 | 425.63 | 171.60 | 247.26 | 270.71 | 301.29 | |||||||||||
EBITDA | 81.50 | 79.26 | 73.58 | 81.25 | 87.08 | 40.95 | 117.42 | 160.73 | 210.25 | 231.67 | ||||||||||
Depreciation/Amortization | 35.33 | 30.53 | 30.68 | 29.75 | 32.97 | 33.32 | 34.94 | 39.27 | 40.08 | 41.31 | ||||||||||
PBIT | 46.17 | 48.73 | 42.90 | 51.50 | 54.11 | 7.63 | 82.48 | 121.46 | 170.17 | 190.36 | ||||||||||
Interest & Other Items | 7.42 | 7.91 | 8.90 | 6.87 | 5.92 | 3.34 | 3.41 | 4.28 | 4.06 | 4.89 | ||||||||||
PBT | 38.75 | 40.82 | 34.00 | 44.63 | 48.19 | 4.29 | 79.07 | 117.18 | 166.11 | 185.47 | ||||||||||
Taxes & Other Items | 14.32 | 14.57 | 12.90 | 16.21 | 4.57 | 1.96 | 20.45 | 31.03 | 42.15 | 47.24 | ||||||||||
Net Income | 24.43 | 26.25 | 21.10 | 28.42 | 43.62 | 2.33 | 58.62 | 86.15 | 123.96 | 138.23 | ||||||||||
EPS | 2.66 | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 13.52 | 15.08 | ||||||||||
DPS | 1.80 | 1.80 | 1.50 | 1.60 | 0.00 | 0.00 | 2.50 | 3.00 | — | 3.00 | ||||||||||
Payout ratio | 0.68 | 0.63 | 0.65 | 0.52 | 0.00 | 0.00 | 0.39 | 0.32 | 0.00 | 0.20 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Indraprastha Medical Corporation Ltd | 32.26 | 8.37 | — |
Apollo Hospitals Enterprise Ltd | 114.66 | 14.07 | 0.22% |
Max Healthcare Institute Ltd | 89.33 | 11.24 | 0.15% |
Fortis Healthcare Ltd | 77.64 | 5.43 | 0.16% |
Price Comparison
Compare INDRAMEDCO with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Increased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has increased by 2.61%
Top 3 Mutual Funds holding Indraprastha Medical Corporation Ltd
Funds (Top 3) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Quant Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.3713% | Percentage of the fund’s portfolio invested in the stock 0.37% | Change in the portfolio weight of the stock over the last 3 months 0.19% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 84/109 (+9) |
Motilal Oswal Quant Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0085% | Percentage of the fund’s portfolio invested in the stock 1.10% | Change in the portfolio weight of the stock over the last 3 months 1.10% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 74/138 (+16) |
Quant Healthcare Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0000% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months -5.28% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/30 (-2) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 13, 2024
Dividend/Share
₹4.50
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 15, 2023
Dividend/Share
₹3.00
Ex DateEx Date
Sep 15, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2022
Cash Dividend
Ex DateEx DateSep 12, 2019
Dividend/Share
₹1.60
Ex DateEx Date
Sep 12, 2019
Cash Dividend
Ex DateEx DateSep 12, 2018
Dividend/Share
₹1.50
Ex DateEx Date
Sep 12, 2018
Indraprastha Medical Corporation announced that the 36th Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live
Net profit of Indraprastha Medical Corporation rose 46.79% to Rs 44.77 crore in the quarter ended June 2024 as against Rs 30.50 crore during the previous quarter ended June 2023. Sales rose 13.49% to Rs 347.86 crore in the quarter ended June 2024 as against Rs 306.51 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales347.86306.51 13 OPM %19.3015.42 - PBDT70.6350.04 41 PBT59.5940.23 48 NP44.7730.50 47 Powered by Capital Market - Live
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 5 August 2024.Powered by Capital Market - Live
Indraprastha Medical Corp hits 52-week high after HDFC Bank sells 27.8 lakh shares
Khaitan (India) Ltd leads gainers in ‘B’ group
Indraprastha Medical Corporation standalone net profit rises 108.03% in the September 2022 quarter
Board of debt-free multibagger stock fixes record date for dividend
Indraprastha Medical Corporation reports standalone net profit of Rs 15.44 crore in the June 2021 quarter
Indraprastha Medical Corporation Q4 profit rises 132.5% to Rs15.10cr
Indraprastha Medical Q4 PAT grows 132% to Rs 15 cr
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 9.85%, vs industry avg of 10.02%
Decreasing Market Share
Over the last 5 years, market share decreased from 2.15% to 2.04%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 34.26%, vs industry avg of 42.9%